Pharmaceutical tariffs included in new US-EU trade deal, White House saysnews2025-07-28T17:20:55+00:00July 28th, 2025|Endpoints News|
Roche doubles down on its Alzheimer’s ambitions as next-gen amyloid-lowering drug excites scientistsnews2025-07-28T15:18:41+00:00July 28th, 2025|Endpoints News|
Private equity firms eye $3B deal for vaccine maker Bavarian Nordicnews2025-07-28T12:29:08+00:00July 28th, 2025|Endpoints News|
FDA investigates death of boy who got Elevidys, Roche says death unrelated to therapynews2025-07-26T09:32:16+00:00July 26th, 2025|Endpoints News|
CHMP backs Lilly’s Alzheimer’s drug in certain patients, Gilead’s twice-yearly HIV prevention shot, among othersnews2025-07-25T15:17:24+00:00July 25th, 2025|Endpoints News|
Updated: Bristol Myers snags Cristian Massacesi from AstraZeneca as its new chief medical officernews2025-07-25T14:39:55+00:00July 25th, 2025|Endpoints News|
Pharma companies slow down their manufacturing projects in Ireland, data shownews2025-07-25T14:29:24+00:00July 25th, 2025|Endpoints News|
CHMP recommends against Elevidys’ approval in Europenews2025-07-25T10:33:38+00:00July 25th, 2025|Endpoints News|
How Sarepta’s crisis over patient deaths unfolded, and what happens nextnews2025-07-24T18:13:51+00:00July 24th, 2025|Endpoints News|
Two House lawmakers seek biotech investments to counter Chinanews2025-07-24T17:49:36+00:00July 24th, 2025|Endpoints News|
